Pharmacology, Toxicology and Pharmaceutical Science
Adrenal Insufficiency
5%
Adverse Event
15%
Adverse Outcome
9%
All Cause Mortality
13%
Allergic Asthma
9%
Ampicillin
6%
Antibiotic Agent
11%
Antibiotics
9%
Antihistaminic Agent
9%
Antivitamin K
18%
Asthma
100%
Case-Control Study
9%
Chronic Obstructive Lung Disease
27%
Chronic Urticaria
9%
Cohort Study
9%
Comorbidity
11%
CYP1A2
10%
CYP2C19
9%
CYP3A4
9%
Desipramine
7%
Drug Comparison
9%
Drug Utilization
9%
Dupilumab
9%
Imipramine
18%
Interleukin 5
9%
Mephenytoin
13%
Mepolizumab
18%
Mortality Rate
6%
Omalizumab
36%
Phenprocoumon
9%
Population Study
10%
Prevalence
10%
Prospective Cohort Study
9%
Randomized Clinical Trial
9%
Reslizumab
9%
Route of Administration
9%
Sparteine
10%
Tramadol
9%
Vitamin D
9%
Warfarin
9%
Medicine and Dentistry
Adverse Event
14%
Alternative Medicine
9%
Antibiotics
5%
Anticoagulation
9%
Asthma
66%
Asthma Control Questionnaire
9%
Breathing
9%
Bronchial Thermoplasty
9%
Case-Control Study
9%
Chest Physiotherapy
10%
Chronic Obstructive Pulmonary Disease
9%
Cohort Analysis
9%
Drug Comparison
9%
Hazard Ratio
15%
Interleukin 5
9%
Mepolizumab
9%
Meta-Analysis
9%
Neurofibromatosis Type I
9%
Patient with Asthma
14%
Pediatrics Patient
9%
Phenprocoumon
9%
Prevalence
5%
Prospective Cohort Study
9%
Quality of Life
19%
Randomized Clinical Trial
9%
Randomized Controlled Trial
9%
Reslizumab
9%
Severe Asthma
22%
Specialist Care
27%
Spontaneous Pneumothorax
9%
Systematic Review
9%
Tramadol
18%
Vitamin D
9%
Vitamin K Antagonist
9%
